SynAct Pharma AB (publ) (“SynAct”) today announced that the company will host a Capital Markets Day in Stockholm on May 5, 2023 for investors, analysts and media. It will be held at GT30 Grev Ture.
Presentations will be made by members of SynAct’s management team as well as invited key opinion leaders. The program will include an in depth overview of the company’s clinical development program. There will be moderated Q&A sessions following the presentations.
The program will be held in English and run from 13:00 to 16:00 CEST and will be accessible through a webcast via the company’s website. The presentations will be available on the company’s website after the event. Further details around the agenda and invited speakers will follow in April. Drinks and a light buffet will be served.
If you wish to attend, please register now via email to: [email protected].
The information was submitted, through the agency of the contact person below, for publication at 07:00 a.m CEST on March 28, 2023